Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 5/20 | 0.49 |
| ▸ | CNR1 | P21554 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | SCD | O00767 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6963617 | 0.88 | CSNK1D (0.54) | ALOX5CNR1MAPTMAOBNPC1 | |
| SCHEMBL6963863 | 0.88 | LTA4H (0.52) | ALOX5CNR1MAPTMAOBNPC1 | |
| SCHEMBL6956223 | 0.87 | MAPT (0.49) | ALOX5CNR1MAPTMAOBNPC1 | |
| SCHEMBL6955042 | 0.85 | ALOX5 (0.51) | ALOX5MAPTNPC1RAB9APOLB | |
| SCHEMBL6958388 | 0.83 | ALOX5 (0.51) | ALOX5CNR1MAPTNPC1RAB9A | |
| SCHEMBL8891824 | 0.82 | MAPT (0.54) | ALOX5CNR1MAPTNPC1RAB9A | |
| SCHEMBL6959559 | 0.82 | ALOX5 (0.52) | ALOX5MAPTMAOBNPC1RAB9A | |
| SCHEMBL6958932 | 0.81 | FPR2 (0.51) | ALOX5MAPTNPC1RAB9APOLB | |
| SCHEMBL6959133 | 0.80 | ALOX5 (0.52) | ALOX5CNR1MAPTNPC1RAB9A | |
| SCHEMBL6961755 | 0.80 | ALOX5 (0.52) | ALOX5MAPTNPC1RAB9APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0540143-B1 | Compounds and methods for inhibition of HIV and related viruses | MEDIVIR AB (SE) | 2003-02-05 | — | — | EP | disclosed |
| US-5714503-A | Compounds and methods for inhibition of HIV and related viruses | MEDIVIR AB (SE) | 1998-02-03 | — | — | US | disclosed |
| US-5593993-A | VIRICIDES FOR HTLV TREATMENT OF AIDS | MEDIVIR AB (SE) | 1997-01-14 | — | — | US | disclosed |
| EP-0540143-A2 | Compounds and methods for inhibition of HIV and related viruses | Medivir Aktiebolag (SE) | 1993-05-05 | — | — | EP | disclosed |
| WO-1993003022-A1 | COMPOUNDS AND METHODS FOR INHIBITION OF HIV AND RELATED VIRUSES | MEDIVIR AB (SE) | 1993-02-18 | — | — | WO | disclosed |